Advances and perspectives of proteolysis targeting chimeras (PROTACs) in drug discovery-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Advances and perspectives of proteolysis targeting chimeras (PROTACs) in drug discovery

Published:2022-08 Issue: Volume:125 Page:105848
ISSN:0045-2068
Container-title:Bioorganic Chemistry
language:en
Short-container-title:Bioorganic Chemistry

Author:

Xi Jia-Yue,Zhang Ru-Yue,Chen Ke,Yao Lin,Li Mu-Qiong,Jiang Ru,Li Xiao-Ye,Fan Li

Funder

Natural Science Foundation of Shaanxi Province

Air Force Medical University

Natural Science Basic Research Program of Shaanxi Province

Publisher

Elsevier BV

Subject

Organic Chemistry,Drug Discovery,Molecular Biology,Biochemistry

Reference158 articles.

1. The druggable genome and support for target identification and validation in drug development;Finan;Sci. Transl. Med.,2017

2. Understanding the Metabolism of Proteolysis Targeting Chimeras (PROTACs): The Next Step toward Pharmaceutical Applications;Goracci;J. Med. Chem.,2020

3. Small-molecule PROTACs: An emerging and promising approach for the development of targeted therapy drugs;An;EBioMedicine,2018

4. Targeted protein degradation: elements of PROTAC design;Paiva;Curr. Opin. Chem. Biol.,2019

5. PROteolysis TArgeting Chimeras (PROTACs) as emerging anticancer therapeutics;Khan;Oncogene,2020

Cited by 20 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Unveiling a new strategy for PDIA1 inhibition: Integration of activity-based probes profiling and targeted degradation;Bioorganic Chemistry;2024-09

2. PROTAC unleashed: Unveiling the synthetic approaches and potential therapeutic applications;European Journal of Medicinal Chemistry;2024-09

3. Estrogen Receptor Alpha Mutations, Truncations, Heterodimers, and Therapies;Endocrinology;2024-04-21

4. Role of protein degradation systems in colorectal cancer;Cell Death Discovery;2024-03-14

5. Design, synthesis, and biological evaluation of first-in-class indomethacin-based PROTACs degrading SARS-CoV-2 main protease and with broad-spectrum antiviral activity;European Journal of Medicinal Chemistry;2024-03

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3